Your shopping cart is currently empty

EA-C15 is a potent and selective TEAD inhibitor with an IC50 value of 0.34 μM. It covalently binds to the palmitoylation site of TEAD, thereby blocking palmitoylation and transcriptional activity, inhibiting YAP-dependent cancer cell proliferation, and suppressing the transcription of YAP-TEAD downstream target genes (CTGF and CYR61). EA-C15 is applicable in cancer research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | EA-C15 is a potent and selective TEAD inhibitor with an IC50 value of 0.34 μM. It covalently binds to the palmitoylation site of TEAD, thereby blocking palmitoylation and transcriptional activity, inhibiting YAP-dependent cancer cell proliferation, and suppressing the transcription of YAP-TEAD downstream target genes (CTGF and CYR61). EA-C15 is applicable in cancer research. |
| Targets&IC50 | TEAD:0.34 μM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.